Skip to main content

and
  1. Article

    Open Access

    Genome wide association study and genomic risk prediction of age related macular degeneration in Israel

    The risk of develo** age-related macular degeneration (AMD) is influenced by genetic background. In 2016, the International AMD Genomics Consortium (IAMDGC) identified 52 risk variants in 34 loci, and a poly...

    Michelle Grunin, Daria Triffon, Gala Beykin, Elior Rahmani in Scientific Reports (2024)

  2. No Access

    Article

    Molecular Biomarkers for Glaucoma

    This article summarizes the current studies on molecular biomarkers with potential implications in diagnosis, prognosis, and response to treatment in patients with glaucoma.

    Gala Beykin, Jeffrey L. Goldberg in Current Ophthalmology Reports (2019)

  3. Article

    Open Access

    Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: “real life” long-term outcome

    To evaluate the long-term outcome of bevacizumab therapy for neovascular age related macular degeneration (NVAMD) in the setting of a clinic.

    Gala Beykin, Michelle Grunin, Edward Averbukh, Eyal Banin in BMC Ophthalmology (2015)